Melanie Ivanov, in Sacramento, CA - Psychologist

Melanie Ivanov, is a Psychologist based in Sacramento, California. Melanie Ivanov is licensed to practice in * (Not Available) (license number ) and her current practice location is 2335 American River Dr Ste 301, Sacramento, California. She can be reached at her office (for appointments etc.) via phone at (916) 467-8353.

NPI number for Melanie Ivanov is 1407629124 and her current mailing address is Po Box 51, Roseville, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1407629124.

Contact Information

	Melanie Ivanov,
	2335 American River Dr Ste 301, Sacramento, CA 95825-7088
	(916) 467-8353
	Not Available

Healthcare Provider's Profile

Full Name	Melanie Ivanov
Gender	Female
Speciality	Psychologist
Location	2335 American River Dr Ste 301, Sacramento, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1407629124
Provider Enumeration Date: 11/03/2023
Last Update Date: 11/03/2023

Medical Identifiers

Medical identifiers for Melanie Ivanov such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1407629124	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Melanie Ivanov is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Melanie Ivanov, Po Box 51, Roseville, CA 95678-0051 Ph: (916) 467-8353	Melanie Ivanov, 2335 American River Dr Ste 301, Sacramento, CA 95825-7088 Ph: (916) 467-8353

News Archive

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from AUGMENT/COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) for the treatment of Chronic Obstructive Pulmonary Disease (COPD), delivered in the Pressair™ inhaler (Genuair® outside the USA).

Study sheds light on the biological underpinnings of obesity

A new neuroscience study sheds light on the biological underpinnings of obesity. The in vivo study, published in the January 8 issue of the Journal of Neuroscience, reveals how a protein in the brain helps regulate food intake and body weight. The findings reveal a potential new avenue for the treatment of obesity and may help explain why medications that are prescribed for epilepsy and other conditions that interfere with this protein, such as gabapentin and pregabalin, can cause weight gain.

Increased Vegetable Intake Fails to Slow Prostate Cancer Progression, Study Finds

Researchers in the United States have conducted a study investigating whether a telephone-based interventional program encouraging an increased intake of vegetables would slow disease progression among patients with early-stage prostate cancer.

Altarum Institute awarded $19.6M ARRA funds to serve as lead agent in establishing M-CEITA

Ann Arbor-based Altarum Institute has been awarded a grant of $19,619,990 by the U.S. Department of Health and Human Services to serve as the lead agent in establishing Michigan's health information technology regional extension center, the Michigan Center for Effective IT Adoption (M-CEITA, www.mceita.org). The grant will be administered through the Office of the National Coordinator for Health Information Technology and managed and sponsored by Altarum. It is expected to create over 100 new jobs in Michigan.

Women taking hormonal contraceptives are at highest risk of FSD: Study

Women taking non-oral and oral hormonal contraceptives were at highest risk of Female Sexual Dysfunction, according to a study of female German medical students published today in The Journal of Sexual Medicine. Interestingly, women taking non-hormonal contraceptives were at lowest risk for FSD, more than women not using any contraceptive.

Psychologist in Sacramento, CA

Brandi Hawk, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3671 Business Dr, Suite 110, Sacramento, CA 95820 Phone: 916-734-3125
Dr. Oscar Steven Escobar, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 1500 W El Camino Ave # 420, Sacramento, CA 95833 Phone: 201-240-2495
Dr. Edward E. Hall, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 418 Alhambra Blvd, Sacramento, CA 95816 Phone: 916-441-2210 Fax: 916-442-7002
Dr. Hengameh Roohi, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3000 T St, Sacramento, CA 95816 Phone: 916-993-2677
Dr. Margaret See-kee Lee, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2530 J St, Suite 310, Sacramento, CA 95816 Phone: 858-354-6999 Fax: 619-688-9222
Dr. Tiffany Rose Mimms, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1521 Corporate Way, Ste 200, Sacramento, CA 95831 Phone: 916-216-8433
Dr. Melissa L Jinariu, PSY.D., LMFT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3671 Business Center Dr., Sacramento, CA 95820 Phone: 916-734-2278 Fax: 916-734-4150

Melanie Ivanov, - Psychologist in Sacramento, CA